Syncom Formulations (India) Board of Directors
Get the latest insights into the leadership at Syncom Formulations (India). Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Kedarmal Shankarlal Bankda | Exe.Chairman & W T D |
| Mr. Vijay Shankarlal Bankda | Managing Director |
| Mrs. Rinki Ankit Bankda | Whole Time Director |
| Mrs. Ruchi Jindal | Independent Woman Director |
| Mr. Ritesh Kumar Lunkad | Independent Director |
| Mr. Ankit Jain | Independent Director |
Syncom Formulations (India) Share price
SYNCOMF
17.15
0.07 (-0.41%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:48 IST
BUYSELL
Today's High
17.51
Today's Low
17.05
52 Week Low
14.10
52 Week High
27.90
The current prices are delayed, login to your account for live prices
LoginSyncom Formulations (India) FAQs
The board at Syncom Formulations (India) consists of experienced professionals, including Mr. Kedarmal Shankarlal Bankda , Mr. Vijay Shankarlal Bankda , and others, overseeing the company’s strategic and corporate governance.
Directors at Syncom Formulations (India) are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Kedarmal Shankarlal Bankda is the current chairman at Syncom Formulations (India).
Executive directors at Syncom Formulations (India) are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Syncom Formulations (India) adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Syncom Formulations (India), board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.